AcquisitionMar 30, 2026, 03:48 AM
Abbott to Acquire Exact Sciences for $105 per Share in Cash
AI Summary
Abbott Laboratories has entered into a definitive agreement to acquire Exact Sciences Corporation for $105.00 per share in cash. The acquisition will be completed through a merger of a wholly-owned subsidiary of Abbott with and into Exact Sciences, with Exact Sciences surviving as a subsidiary of Abbott. This acquisition expands Abbott's diagnostics portfolio and presence in the cancer screening market.
Key Highlights
- Abbott will acquire Exact Sciences for $105.00 per share in cash.
- The merger is subject to customary closing conditions, including shareholder approval and regulatory approvals.
- Exact Sciences will become a wholly-owned subsidiary of Abbott upon completion of the merger.